HRA001061
Title:
Peptide-based neoantigen vaccine for pancreatic cancer
Release date:
2023-07-20
Description:
To further explore the application of novel cancer immunotherapy for pancreatic cancer, personalized neoantigen peptide vaccines were developed in our study for the treatment of advanced pancreatic cancers.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
pancreatic cancer
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
Pancreatic Cancer WES
Contact person:
Yang Liu
Email:
yangliuqq2003@163.com
Description:
To further explore the application of novel cancer immunotherapy for pancreatic cancer, personalized neoantigen peptide vaccines were developed in our study for the treatment of advanced pancreatic cancers.
Individuals & samples
Submitter:   Yang Liu / yangliuqq2003@163.com
Organization:   Zhejiang Provincial People's Hospital
Submission date:   2021-07-20
Requests:   -